A Retrospective Study Analyzing the Appropriateness of Initial Treatment of Clostridium difficile in Patients with Active Malignancy.
Aaron FisherPradeep KhanalEwa GniadoLeila KhaddourMolly OroseyIsmail HaderSiddhartha YadavAlexandra HalalauPublished in: Gastroenterology research and practice (2018)
Our results support the initial use of vancomycin or a combination (metronidazole and vancomycin) versus metronidazole in patients with CDI and active malignancy.